期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Clinical application of real time-polymerase chain reaction in determining cytomegalovirus viral DNA load in renal transplant recipients 被引量:2
1
作者 ZHANG Chuan-bao LAI Hui-ying +2 位作者 XU Hong-tao WANG Da-guang XIAO Fei 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第19期3575-3577,共3页
Background Cytomegalovirus (CMV) remains a significant clinical problem among immunosuppressed renal transplant patients. Quantitative PCR assays have become the most common methods in the determination of CMV infec... Background Cytomegalovirus (CMV) remains a significant clinical problem among immunosuppressed renal transplant patients. Quantitative PCR assays have become the most common methods in the determination of CMV infections in transplant patients. This study was to determine the relationship between CMV infection and the acute rejection of the transplanted kidney. Methods Plasma samples from 77 renal transplant patients that were pre-transplant negative for CMV infection were tested using reaD-time quantitative PCR and CMV gene-specific primers. The detected viral loads were retrospectively compared with the acute rejection rate and the chronic or mild rejection rates of the renal transplant. Results CMV-DNA was detected in 29 of 77 recipients, yielding a positive rate of detection of 37.7% for this procedure. Twelve of the 21 recipients (57.1%) who suffered acute rejection had positive CMV-DNA. Among the 56 recipients suffered from chronic or mild rejection, 17 (30.4%) had positive CMV-DNA plasma. Moreover, of the 29 recipients who had detectable CMV-DNA after transplant, 12 (41.4%) suffered from acute rejection; of the 48 recipients with undetectable CMV-DNA, only nine (18.8%) developed acute rejection. Post-transplant patients with acute rejection had a higher rate (57.1% vs. 30.4%, P=0.03) of post-transplant CMV infection than those with chronic or mild rejection. Conclusion CMV infection is a risk factor of acute renal transplant rejection and CMV infection should be prevented and treated in renal transplant recipients. 展开更多
关键词 real time-polymerase chain reaction renal transplant cytomegalovirus infection REJECTION
原文传递
组蛋白乙酰化酶hMOF在肾透明细胞癌组织中的表达及其临床意义 被引量:3
2
作者 迟长亮 芦志华 +5 位作者 管旌旌 王勇 唐宇哲 蔡勇 金景姬 王春喜 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2012年第2期303-307,I0004,共6页
目的:检测组蛋白乙酰化酶hMOF蛋白在肾透明细胞癌(RCC)组织中的表达,探讨其与肾癌患者临床病理特征的关系。方法:采用免疫组织化学、qRT-PCR方法检测正常肾组织与肾癌组织中hMOF的表达,分析hMOF表达与肾癌患者临床病理特征的关系。... 目的:检测组蛋白乙酰化酶hMOF蛋白在肾透明细胞癌(RCC)组织中的表达,探讨其与肾癌患者临床病理特征的关系。方法:采用免疫组织化学、qRT-PCR方法检测正常肾组织与肾癌组织中hMOF的表达,分析hMOF表达与肾癌患者临床病理特征的关系。结果:qRT-PCR结果显示,9例肾癌患者中有4例(44.4%)hMOF的mRNA水平显著下降。免疫组织化学结果显示,39例(62.1%,39/66)肾癌组织中hMOF蛋白表达为阴性或弱阳性,而癌旁正常组织仅4例(6.1%,4/66)hMOF蛋白的表达为阴性或弱阳性,2组比较差异有统计学意义(P〈0.05)。其中肾癌组织FuhrmanⅢ中hMOF表达明显低于FuhrmanⅠ~Ⅱ,差异有统计学意义(P〈0.05)。中低分化肾癌组织hMOF表达明显低于高分化组,差异有统计学意义(P〈0.05)。hMOF蛋白表达水平降低的肾癌患者其区域淋巴结及远处器官转移的风险增高。结论:hMOF蛋白在肾癌组织、尤其病理分期及Fuhrman分级增高的肾癌组织中的表达显著下降,提示hMOF蛋白可能与肾癌的发生、发展及恶性程度有关。 展开更多
关键词 hMOF 肾肿瘤 免疫组织化学 实时定量聚合酶链反应
下载PDF
Early constraint-induced movement therapy affects behavior and neuronal plasticity in ischemia-injured rat brains 被引量:12
3
作者 Xi-Hua Liu Hong-Yan Bi +2 位作者 Jie Cao Shuo Ren Shou-Wei Yue 《Neural Regeneration Research》 SCIE CAS CSCD 2019年第5期775-782,共8页
Constraint-induced movement therapy is an effective rehabilitative training technique used to improve the restoration of impaired upper extremity movement after stroke. However, whether constraint-induced movement the... Constraint-induced movement therapy is an effective rehabilitative training technique used to improve the restoration of impaired upper extremity movement after stroke. However, whether constraint-induced movement therapy is more effective than conventional rehabilitation in acute or sub-acute stroke remains controversial. The aim of the present study was to identify the optimal time to start constraint-induced movement therapy after ischemic stroke and to explore the mechanisms by which constraint-induced movement therapy leads to post-stroke recovery. Sixty-four adult male Sprague-Dawley rats were randomly divided into four groups: sham-surgery group, cerebral ischemia/reperfusion group, early constraint-induced movement therapy group, and late constraint-induced movement therapy group. Rat models of left middle cerebral artery occlusion were established according to the Zea Longa line embolism method. Constraint-induced movement therapy was conducted starting on day 1 or day 14 in the early constraint-induced movement therapy and late constraint-induced movement therapy groups, respectively. To explore the effect of each intervention time on neuromotor function, behavioral function was assessed using a balance beam walking test before surgery and at 8 and 21 days after surgery. The expression levels of brain-derived neurotrophic factor, nerve growth factor and Nogo receptor were evaluated using real time-polymerase chain reaction and western blot assay to assess the effect of each intervention time. The results showed that the behavioral score was significantly lower in the early constraint-induced movement therapy group than in the cerebral ischemia/reperfusion and late constraint-induced movement therapy groups at 8 days. At 21 days, the scores had significantly decreased in the early constraint-induced movement therapy and late constraint-induced movement therapy groups. At 8 days, only mild pyknosis appeared in neurons of the ischemic penumbra in the early constraint-induced movement therapy group, which was distinctly better than in the cerebral ischemia/reperfusion group. At 21 days, only a few vacuolated cells were observed and no obvious inflammatory cells were visible in late constraint-induced movement therapy group, which was much better than at 8 days. The mRNA and protein expression levels of brain-derived neurotrophic factor and nerve growth factor were significantly higher, but expression levels of Nogo receptor were significantly lower in the early constraint-induced movement therapy group compared with the cerebral ischemia/reperfusion and late constraint-induced movement therapy groups at 8 days. The changes in expression levels at 21 days were larger but similar in both the early constraint-induced movement therapy and late constraint-induced movement therapy groups. Besides, the protein nerve growth factor level was higher in the late constraint-induced movement therapy group than in the early constraint-induced movement therapy group at 21 days. These results suggest that both early(1 day) and late(14 days) constraint-induced movement therapy induces molecular plasticity and facilitates functional recovery after ischemic stroke, as illustrated by the histology. The mechanism may be associated with downregulation of Nogo receptor expression and upregulation of brain-derived neurotrophic factor and nerve growth factor expression. 展开更多
关键词 NERVE REGENERATION ischemic stroke rehabilitation constraint-induced movement therapy NERVE growth factors functional recovery neuronal plasticity real time-polymerase chain reaction western BLOT assay rats neural REGENERATION
下载PDF
Survivin mRNA expression in urine as a biomarker for patients with transitional cell carcinoma of bladder 被引量:15
4
作者 HOU Jian-quan HE Jun +2 位作者 WEN Duan-gai CHEN Zi-xing ZENG Jian 《Chinese Medical Journal》 SCIE CAS CSCD 2006年第13期1118-1120,共3页
Transitional cell carcinoma (TCC) of bladder is the most common malignant tumor in uropoiesis system. Up to date, there is still lack of an ideal marker for the diagnosis of TCC except CT and MRI imaging and cystosc... Transitional cell carcinoma (TCC) of bladder is the most common malignant tumor in uropoiesis system. Up to date, there is still lack of an ideal marker for the diagnosis of TCC except CT and MRI imaging and cystoscopy. Cystoscopy is an invasive examination, which increases the possibility of urinary tract infection. Urine cytology has low sensitivity (21%--40%) in diagnosis of bladder cancer, especially for those with medium or high differentiation. The specificity is often affected by factors such as specimen collection, urinary tract infection, etc. Detecting the expression of survivin mRNA in urine by real time-PCR is simple in specimen collection and is sensitive and relatively specific, which provides a simple and noninvasive diagnostic method for TCC. Moreover it allows comparing the gene expression levels at different stages and grades of TCC, which can help define malignancy degree of TCC. 展开更多
关键词 transitional cell carcinoma of bladder SURVIVIN real time-polymerase chain reaction
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部